1. Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, Michalek AM, Laughlin R, Nemoto T, Gillenwater KA, Harrington AM, Shields PG (1996) Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA 276: 1494–1501
2. Aragaki CC, Greenland S, Probst-Hensch N, Haile RW (1997) Hieararchical modeling of gene-environment interactions: estimating NAT2 genotype-specific dietary effects on adenomatous polyps. Cancer Epidemiol Biomarkers Prey 6: 307–314
3. Bell DA, Badawi AF, Lang NP, Ilea KF, Kadlubar FF, Hirvonen A (1995) Polymorphism in the N-acetyltransferase I (NAT1) polyadenylation signal: association of NATI*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res 55: 5226–5229
4. Bootsma D, Hoeijmakers JH (1991) The genetic basis of xeroderma pigmentosum. Ann Genet 34: 143–150
5. Cartwright RA, Glashan RW, Rogers HJ, Ahmad RA, Barham Hall D, Higgins E, Kahn MA (1982) Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet 2: 842–845